Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)

NCT03143998 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Business reasons

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC